Oculis Holding AG (OCS) News
Track canonical SquawkNews coverage tagged to OCS, Oculis Holding AG. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 4 indexed stories across 3 publication days and is ordered by the same first-publication timeline used by LiveCast.
M
OCS starts PIONEER-1 trial after first Privosegtor patient treated
OCS says it has treated the first patient in its PIONEER-1 registrational trial of Privosegtor for optic neuritis.
EQUITY | Aug 24, 2026, 08:00 AM UTC
H
Oculis To Submit IND For Privosegtor In Acute MS Relapses In Q4 2026, Backed By Positive FDA Pre-IND Guidance And Prior Optic Neuritis Data
The FDA Division of Neurology provided positive feedback supporting a regulatory pathway for Privosegtor in acute multiple sclerosis (MS) relapses, addressing a significant unmet medical need The FDA confirmed that exist
REGULATION | Aug 03, 2026, 08:01 AM UTC
L
OCS - Oculis Announces Positive FDA Pre-IND Feedback Supporting Privosegtor Development Strategy for Treatment of Acute Multiple Sclerosis R
OCS - Oculis Announces Positive FDA Pre-IND Feedback Supporting Privosegtor Development Strategy for Treatment of Acute Multiple Sclerosis Relapses
REGULATION | Aug 03, 2026, 08:00 AM UTC
H
Intuitive Surgical, Netflix And Other Big Stocks Moving Lower In Friday’s Pre-Market Session
U.S. stock futures were lower this morning, with the Nasdaq 100 futures falling around 2% on Friday. Shares of Intuitive Surgical Inc (NASDAQ: ISRG ) fell sharply in pre-market trading after the company reported second-q
EARNINGS | Jul 17, 2026, 12:02 PM UTC